Follow the latest coverage, related explainers and connected technology stories.
Evvy announced that it raised $40 million in a Series B round led by Catalio Capital Management, as it plans to expand its vaginal microbiome analysis platform and enter the fertility field. The company is building a database linking biomarkers with symptoms, treatments, and health outcomes, but most new applications remain under study.